monoamine oxidase inhibitor
Objective: Assess if a classroom-based pharmacy education service for hospitalized headache patients newly prescribed a monoamine oxidase inhibitor (MAOI) results in, 1) higher self-perceived medication knowledge, or 2) lower perceived risk of using MAOIs.
Subjects: Individuals admitted to an inpatient headache unit over a five month period
Methods: Patient survey administered before and after the education service to any patient newly prescribed an MAOI.
Results: Seventy-eight individuals completed the study. Paired-samples t-tests showed that for each of the four items related to self-perceived medication knowledge, the scores reflected higher knowledge after the MAOI class compared to before the class (p < 0.05). For three out of the four items related to perceived risk of using MAOIs, the scores reflected a lower level of perceived risk after the MAOI class compared to before the class (p < 0.05). One item did not significantly change: "The MAOI prescribed for me is just as good as other products available for treating headache." Conclusion: Our results demonstrate a pharmacist-conducted, classroom-based teaching method for newly prescribed MAOI patients can result in higher self-perceived medication knowledge and lower perceived risks.
Wenzel RG, Schommer JC. Hospitalized Patients' Perceived Knowledge and Risk of Monoamine Oxidase Inhibitor Medications Before and After a Pharmacist's Classroom-Based Education. Inov Pharm. 2010;1(1): Article 5. https://pubs.lib.umn.edu/innovations/vol1/iss1/5.